Endpoints News
Thank you for reading!
basic
UPGRADE
M T W Th Fri
10 December, 2021
Sema4 Advance best-in-class precision therapies by uncovering differentiated insights powered by advanced bioinformatics and systems biology.
presented by Catalent
Op­ti­miz­ing Oral Drug De­liv­ery us­ing Zy­dis® Oral­ly Dis­in­te­grat­ing Tablet Tech­nol­o­gy to Ad­dress Pa­tient Chal­lenges
news
Moderna says its mRNA flu vaccine cleared early studies, pivotal trial on its way
ENDPOINTS NEWS
Bioregnum
Billionaire BioNTech backers have been kicking the tires at Novartis' big generics arm — report
ENDPOINTS NEWS
Viatris and Biocon mull pooling their biosimilars into a $10B standalone company — report
ENDPOINTS NEWS
Snakebit Angion reports another miss for lead program, as biotech prepares to shift its 'primary focus'
ENDPOINTS NEWS
MarketingRx: GlaxoSmithKline enlisted Harris Poll for a severe asthma survey — results point to more outreach
ENDPOINTS NEWS
Peer Review
Flagship on center stage: Axcella’s new CMO likens the biotech to ‘professional sports team’; Life after the FDA takes shape for Stephen Hahn as a chief executive
ENDPOINTS NEWS
Covid-19 roundup: UK preps for a wave of Omicron cases; Bourla suggests a fourth dose might be necessary
ENDPOINTS NEWS
Webinar: Nonviral production of allogenic CAR-Tscm Cells
In this webinar, learn about Poseida Therapeutics’ approach to transitioning from autologous to fully allogeneic CAR-T therapy manufacturing.
sponsored by Sartorius
in case you missed it
1.
Will ‘original antigenic sin’ undermine Omicron boosters? New research suggests ‘no’
ENDPOINTS NEWS
2.
Radius falters after a PhIII osteoporosis fail and a breast cancer disappointment, sending shares plummeting
ENDPOINTS NEWS
3.
With new pivotal data, uniQure and CSL Behring dash to the FDA with a potential blockbuster gene therapy for hemophilia B
ENDPOINTS NEWS
4.
Bioregnum
Promising to slim down and speed up, the ‘new’ J&J shakes up the executive committee ahead of the big split
ENDPOINTS NEWS
5.
UPDATED: FDA adcomm votes unanimously against Reata's potential Alport syndrome treatment
ENDPOINTS NEWS
6.
Struggling Aprea wins a reprieve as FDA lifts one of the holds on their only drug
ENDPOINTS NEWS
7.
Cingulate prices a downsized public offering as IPO party appears to die down
ENDPOINTS NEWS
8.
Atlas, F-Prime launch K36 Therapeutics to advance oncology molecule for elusive epigenetic target
ENDPOINTS NEWS
9.
Eir Ventures tops up life sciences fund with $138M for Nordic biotechs
ENDPOINTS NEWS
10.
Masayuki Uemura, Creator Of The NES And SNES, Dies At 78
Kotaku
Endpoints Careers
Discovery Informatics (Research Associate-Scientist)
Karuna Therapeutics
Boston, MA, USA
Process Development, Drug Product, CMC (Principal Scientist-Senior Manager)
Karuna Therapeutics
Boston, MA, USA
Associate Director/Director, Biostatistics
Astex Pharmaceuticals
Pleasanton, CA, USA
Research Associate - Sequencing
Adimab, LLC
Lebanon, NH, USA
Recruit talent with Endpoints Careers
Contact Melissa Nazzaro: melissa@endpointsnews.com
Endpoints webinars
Dec 13
2:30pm ET
Different approaches to process development and manufacturing in gene therapy
3M
Dec 14
12:00pm ET
Checkpoint inhibitors: the gut microbiome’s role in anti-tumor response
TD2
Dec 15
12:00pm ET
Enterprise R&D transformation case study: Genentech
Benchling
Dec 16
12:00pm ET
CQV strategies that increase speed-to-market for gene therapy
Project Farma
Jan 18
11:00am ET
Navigating your biopharma drug candidate through early and mid-stage clinical trials
Catalent
Endpoints at #ASH21
Kyle Blankenship will examine the latest cell and gene therapy R&D news out of ASH21 — sign up today.
sponsored by Endpoints News
Arsalan Arif
.

It's a Friday, but we've got a jam-packed weekend of news planned. Kyle Blankenship is headed to ASH to lead our coverage and we're expecting 10+ stories coming out of the conference by early Monday. Check in on the web early and often for the latest. We'll recap it for you with a special report on Monday, December 13, followed by our virtual event Endpoints at #ASH21 at 12pm ET. You can sign up for that and see the entire agenda here.

.
Arsalan Arif
Publisher & Founder, Endpoints News
@AKAarsalan
John Carroll
Editor & Founder
Arsalan Arif
Publisher & Founder
Shehla Shakoor
Managing Director
Igor Yavych
Chief Technical Officer
Mike Peck
Chief Revenue Officer
Valentin Manov
Creative Director
Kyle Blankenship
Managing Editor
Amber Tong
Senior Editor
Beth Snyder Bulik
Senior Editor
Zachary Brennan
Senior Editor
Jason Mast
Editor
Nicole DeFeudis
Editor
Max Gelman
Editor
Josh Sullivan
Associate Editor
Kathy Wong
Assistant Editor
Melissa Nazzaro
Sales Director
Cassidy Murphy
Sales Associate
Jaime Bruder
Sr. Operations Manager
Kara Thibault
Operations Manager
Jordan Collins
Operations
Lirra Selibio
Subscriptions
Dawn Cleveland
Controller
Alex Hoffman
Copy Editor
Amanda Florez
Executive Assistant
Alex Lefterov
Graphic Designer
DeAna Catoni
Operations Coordinator
Kari Abitbol
Director, Studio
Julie Notario
Sales Director
Rachel Wilson
Operations Coordinator
Mykola Chornyi
Developer
Derek Graf
Copy/Visuals Editor
Paul Schloesser
Associate Editor
Andriy Tomchyshyn
Lead Developer
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.